China Tower Corporation Limited
China Tower Corporation Limited (CHWRF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for China Tower Corporation Limited (CHWRF), featuring income statements, balance sheets, and cash flow data.
China Tower Corporation Limited (CHWRF) Income Statement & Financial Overview
Explore comprehensive income reports for China Tower Corporation Limited CHWRF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $25.32B | $24.20B | $24.27B | $23.97B |
| Cost of Revenue | $16.57B | $7.77B | $10.32B | $18.09B |
| Gross Profit | $8.76B | $16.43B | $13.95B | $5.88B |
| Gross Profit Ratio | $0.35 | $0.68 | $0.57 | $0.25 |
| R&D Expenses | $0.00 | $0.00 | $2.07M | $2.07M |
| SG&A Expenses | $6.29B | $3.25B | $1.33B | $1.57B |
| Operating Expenses | -$7.58B | $24.58B | $9.50B | $20.29B |
| Total Costs & Expenses | $8.99B | $32.35B | $19.82B | $20.29B |
| Interest Income | $0.00 | $0.00 | $884.95M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $9.40B | $9.40B | $9.40B | $9.40B |
| EBITDA | $14.45B | $11.89B | $13.24B | $13.09B |
| EBITDA Ratio | $0.57 | $0.49 | $0.55 | $0.55 |
| Operating Income | $16.33B | -$8.15B | $3.83B | $3.69B |
| Operating Income Ratio | $0.64 | -$0.34 | $0.16 | $0.15 |
| Other Income/Expenses (Net) | -$12.97B | $11.87B | -$482.16M | $0.00 |
| Income Before Tax | $3.36B | $3.72B | $3.35B | $3.69B |
| Income Before Tax Ratio | $0.13 | $0.15 | $0.14 | $0.15 |
| Income Tax Expense | $784.00M | $898.00M | $803.47M | $904.00M |
| Net Income | $2.58B | $2.82B | $2.55B | $2.78B |
| Net Income Ratio | $0.10 | $0.12 | $0.10 | $0.12 |
| EPS | $0.15 | $0.16 | $0.15 | $0.16 |
| Diluted EPS | $0.15 | $0.16 | $0.15 | $0.16 |
| Weighted Avg Shares Outstanding | $17.48B | $17.47B | $17.45B | $17.51B |
| Weighted Avg Shares Outstanding (Diluted) | $17.48B | $17.47B | $17.45B | $17.51B |
Financial performance has remained strong, with revenue growing from $23.97B in Q1 2024 to $25.32B in Q4 2024. Gross profit continued to perform well, with margins at 35% in the latest quarter. Operating income reached $16.33B in Q4 2024, holding a steady 64% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $14.45B. Net income dropped to $2.58B, keeping EPS at $0.15. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan